CompletedNCT06906224
Control group (clozapine, placebo) for schizophrenia
It tested control group (clozapine, placebo) for schizophrenia.
SchizophreniaDrugFrom 1 Year to 65 Years
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 1 year to 65 years. Other eligibility criteria applied.
- Listed locations
- Wuhu, ChinaSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
Study information
Study start dateStarted: May 1, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 46
- Sponsor
- Chuanfu Song
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- China
- Age range
- From 1 Year to 65 Years
- Official registry ID
- NCT06906224
- Official title
- Effects of Different Doses of Buspirone Combined With Clozapine on Psychiatric Symptoms and Cognitive Function in Patients With Schizophrenia: A Randomised, Double-blind, Placebo-controlled Trial
Recruitment & locations
CompletedWuhu
Questions about this study
Who is behind this study?
The study sponsor is Chuanfu Song.
Did this study involve medication?
Yes. The study involved medication, including Control group (clozapine, placebo), Low-dose group (buspirone tablets, clozapine) and High-dose group (buspirone tablets, clozapine).
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 1 year to 65 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT02435654
5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in China.
CompletedNCT03379597
Dietary Fiber and Probiotics Treatment for schizophrenia
This study is completed in China. It is testing dietary Fiber and Probiotics Treatment for schizophrenia.
CompletedNCT00642369
A 4-week, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia
This study is completed in China. It is testing quetiapine for schizophrenia.